4 news items
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
ENLV
16 Apr 24
expects to initiate following the completion of the safety run-in stage and confirmation by the independent Data and Safety Monitoring Board
Enlivex Announces Topline Results Of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
ENLV
11 Apr 24
advisory boards for sepsis multinational trials, independent clinical evaluation committees and adjudication committees. Dr. François stated, "I am very
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
ENLV
11 Apr 24
in several advisory boards for sepsis multinational trials, independent clinical evaluation committees and adjudication committees. Dr. François stated, "I am
Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
ENLV
26 Feb 24
independent Data Safety Monitoring Board. On top of evaluating the safety, the blinded randomized stage will be statistically powered to assess the efficacy
- Prev
- 1
- Next